Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · IEX Real-Time Price · USD
6.50
-0.01 (-0.15%)
At close: Apr 15, 2024, 4:00 PM
6.64
+0.14 (2.15%)
After-hours: Apr 15, 2024, 7:54 PM EDT
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $675.43 million as of April 15, 2024. Its market cap has decreased by -9.75% in one year.
Market Cap
675.43M
Enterprise Value
428.58M
1-Year Change
-9.75%
Ranking
Category
Stock Price
$6.50
Market Cap Chart
Since March 29, 2018, Cogent Biosciences's market cap has increased from $328.70M to $675.43M, an increase of 105.49%. That is a compound annual growth rate of 12.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 12, 2024 | 676.50M | -0.60% |
| Apr 11, 2024 | 680.60M | -1.51% |
| Apr 10, 2024 | 691.00M | -4.87% |
| Apr 9, 2024 | 726.40M | 7.22% |
| Apr 8, 2024 | 677.50M | -2.84% |
| Apr 5, 2024 | 697.30M | -2.75% |
| Apr 4, 2024 | 717.00M | 0.14% |
| Apr 3, 2024 | 716.00M | 2.08% |
| Apr 2, 2024 | 701.40M | -2.18% |
| Apr 1, 2024 | 717.00M | 2.68% |
| Mar 28, 2024 | 698.30M | 3.07% |
| Mar 27, 2024 | 677.50M | 11.74% |
| Mar 26, 2024 | 606.30M | 0.95% |
| Mar 25, 2024 | 600.60M | -9.55% |
| Mar 22, 2024 | 664.00M | -4.20% |
| Mar 21, 2024 | 693.10M | -2.34% |
| Mar 20, 2024 | 709.70M | 1.49% |
| Mar 19, 2024 | 699.30M | -0.16% |
| Mar 18, 2024 | 700.40M | -4.40% |
| Mar 15, 2024 | 732.60M | 7.80% |
| Mar 14, 2024 | 679.60M | -0.31% |
| Mar 13, 2024 | 681.70M | 3.30% |
| Mar 12, 2024 | 659.90M | -2.29% |
| Mar 11, 2024 | 675.40M | -1.37% |
| Mar 8, 2024 | 684.80M | -1.93% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Varex Imaging | 700.35M |
| Quanterix | 699.23M |
| Longboard Pharmaceuticals | 691.53M |
| Prime Medicine | 687.25M |
| Mind Medicine (MindMed) | 681.74M |
| enGene Holdings | 671.18M |
| Stoke Therapeutics | 662.24M |
| ORIC Pharmaceuticals | 660.28M |